J O Moore

Author PubWeight™ 65.08‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med 1994 5.03
2 Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. N Engl J Med 1995 2.33
3 The syndrome of 5-fluorouracil cardiotoxicity. An elusive cardiopathy. Cancer 1993 2.21
4 Population studies of pepsinogen polymorphism. Am J Hum Genet 1973 1.50
5 Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin. Proc Natl Acad Sci U S A 1984 1.46
6 Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis. Proc Natl Acad Sci U S A 1983 1.41
7 High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 1988 1.40
8 Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine. Blood 2001 1.38
9 Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol 1997 1.36
10 Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol 1999 1.36
11 Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function. Leukemia 2012 1.26
12 Preparation and characterization of lymphocyte-activating factor (LAF) from acute monocytic and myelomonocytic leukemia cells. Cell Immunol 1978 1.25
13 Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study. Blood 1997 1.23
14 CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells. Blood 1989 1.16
15 Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis. Leukemia 2009 1.15
16 Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow. J Natl Cancer Inst 1993 1.12
17 Improved survival in advanced Hodgkin's disease with the use of combined modality therapy. Int J Radiat Oncol Biol Phys 1990 1.06
18 Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720. Leukemia 2011 1.05
19 Facilitated light microscopic cytochemical diagnosis of acute myelogenous leukemia. Cancer Res 1979 1.05
20 High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361). Blood 2001 1.03
21 Predictors of outcome of tricuspid valve replacement in carcinoid heart disease. Am J Cardiol 1995 1.03
22 Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells. Leuk Res 1995 1.02
23 Bowel transit-times in two populations experiencing similar colon-cancer risks. Lancet 1974 1.02
24 The light microscopic demonstration of hydroperoxidase-positive Phi bodies and rods in leukocytes in acute myeloid leukemia. Histochemistry 1978 1.00
25 Disseminated aspergillosis in a renal transplant patient: Diagnostic difficulties re-emphasized. Johns Hopkins Med J 1975 0.94
26 Arthritis syndromes associated with human T cell lymphotropic virus type I infection. Med Clin North Am 1997 0.94
27 Carcinoid tumors: iodine-131 MIBG scintigraphy. Radiology 1989 0.93
28 Detection and partial characterization of human thymus-leukemia antigens. J Natl Cancer Inst 1980 0.92
29 A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 1996 0.91
30 Molecular and cytogenetic characterization of a novel rearrangement involving chromosomes 9, 12, and 17 resulting in ETV6 (TEL) and ABL fusion. Cancer Genet Cytogenet 2005 0.89
31 Intraluminal thrombus and bowel obstruction in acute leukemia due to bleeding Meckel's diverticulum. Am J Med 1986 0.87
32 Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells. Am J Pathol 1988 0.86
33 Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461. Ann Hematol 2004 0.85
34 The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis. Br J Haematol 1991 0.85
35 Craniocerebral plasmacytoma: MR features. AJNR Am J Neuroradiol 1997 0.84
36 Computed tomography of primary retroperitoneal malignancies. J Comput Assist Tomogr 1988 0.83
37 Left axis deviation and left anterior hemiblock among 8,000 Japanese-American men. Am J Cardiol 1975 0.83
38 Right ventricular obstruction secondary to intracardiac metastatic osteosarcoma. Clin Cardiol 1980 0.82
39 I and i antigens on normal and leukemic leukocytes. Cancer 1978 0.82
40 Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine. J Neurosurg 1990 0.82
41 Septic arthritis due to Mycoplasma hominis. Arthritis Rheum 1983 0.82
42 High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic study. Cancer Chemother Pharmacol 1989 0.82
43 Clinicopathologic and cytogenic features of CD34 (My 10)-positive acute nonlymphocytic leukemia. Am J Clin Pathol 1989 0.81
44 Follicular mucinosis as a presenting sign of acute myeloblastic leukemia. J Am Acad Dermatol 1998 0.80
45 Hodgkin's disease presenting as myelofibrosis. Cancer 1989 0.80
46 Leukemia-associated arthritis: identification of leukemic cells in synovial fluid using monoclonal and polyclonal antibodies. Arthritis Rheum 1984 0.80
47 Cytogenetic and molecular analysis of an unusual case of acute promyelocytic leukemia with a t(15;17;17)(q22;q23;q21). Cancer Genet Cytogenet 2003 0.79
48 Hepatosplenic T-cell lymphoma: an unusual case of a gamma delta T-cell lymphoma with a blast-like terminal transformation. Hum Pathol 1994 0.79
49 Acute lymphoblastic leukemia: classification and characterization with antisera to human T-cell and Ia antigens. J Natl Cancer Inst 1979 0.79
50 Deferoxamine treatment as a risk factor for zygomycete infection. J Infect Dis 1989 0.78
51 Medusa cells: the morphology and cytochemistry of common amoeboid variants of eosinophils. Histochem J 1980 0.78
52 Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia. Leukemia 2008 0.78
53 Medusa cells: cytostructure and cytochemistry of amoeboid eosinophils with pseudopod-like processes. Histochem J 1981 0.78
54 Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia. Leuk Res 1998 0.78
55 Prevention of amphotericin B-induced rigors by dantrolene. Arch Intern Med 1986 0.77
56 Chronic lymphocytic leukemia. Cancer 1978 0.77
57 Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes. Am J Clin Pathol 1997 0.76
58 Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection. J Surg Oncol 2001 0.76
59 Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial). Leukemia 1995 0.76
60 Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin. Blood 1989 0.76
61 Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis. Cancer Res 1979 0.75
62 Familial aggregation of multiple myeloma and central nervous system diseases. J Am Geriatr Soc 1989 0.75
63 Specific receptors for phorbol diesters on freshly isolated human myeloid and lymphoid leukemia cells: comparable binding characteristics despite different cellular responses. Blood 1984 0.75
64 Pleural amyloidosis. Arch Pathol Lab Med 1988 0.75
65 Estrogen receptor determination in percutaneous bone marrow biopsies of patients with metastatic breast cancer. Med Pediatr Oncol 1979 0.75
66 Sarcomas in the elderly. Clin Geriatr Med 1987 0.75
67 Pulmonary metastasis from ameloblastoma of the mandible: report of case and review of the literature. J Oral Surg 1980 0.75
68 Mitoxantrone in the treatment of relapsed and refractory acute leukemia. Semin Oncol 1984 0.75
69 Leukopheresis therapy of leukemic reticuloendotheliosis (hairy cell leukemia). Blood 1979 0.75
70 Malignant effusions in recurrent breast cancer: steroid hormone receptor analysis of effusion fluid derived cells. Cancer 1980 0.75
71 LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells. Leukemia 2010 0.75
72 Autologous marrow transplantation for patients with acute myelogenous leukemia--a preliminary report. Exp Hematol 1979 0.75
73 Post transplant CD8+ gammadelta T-cell lymphoma associated with human herpes virus-6 infection. Leuk Lymphoma 1999 0.75
74 A pilot study of etoposide, vinblastine, and doxorubicin plus involved field irradiation in advanced, previously untreated Hodgkin's disease. Cancer 1994 0.75